Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC ...

The stock's fall snapped a five-day winning streak.

Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

Vaccine stocks received a major and sudden boost on January 7, 2025. Here's why these companies are experiencing tailwinds in ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Shortly after President-elect Donald J. Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human ...

Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid ...

Moderna leads vaccine rally amid rising respiratory infections, spurring investment in COVID-19, flu, and RSV solutions.

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Novavax shares are trading higher by 12.4% during Tuesday's session. A recent CDC report highlights a sharp increase in ...

Unusual total active option classes on open include: Getty Images ( GETY ), Nkarta ( NKTX ), Truist Financial ( TFC ), Pac Bio ( PACB ), Enovix ( ENVX ), Novavax ( NVAX ), Nokia ( NOK ), Cerence ( ...

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $7.93 which represents a decrease of $-0.35 or -4.23% from the prior close of $8.28. The stock opened at $8.16 and touched a low of ...